Pro Share Advisors LLC Astrazeneca PLC Transaction History

Pro Share Advisors LLC

$46.4 Billion
Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Pro Share Advisors LLC holds 654,859 shares of AZN stock, worth $58.5 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

654,859

Previous 833,661 21.45%

Holding current value

$58.5 Million

Previous $58.3 Million 13.76%

% of portfolio

0.11%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$68.72 - $82.11 $12.3 Million - $14.7 Million	-178,802 Reduced 21.45%	654,859 $50.2 Million
Q2 2025 Aug 07, 2025	BUY	$64.87 - $75.0 $3.13 Million - $3.62 Million	48,255 Added 6.14%	833,661 $58.3 Million
Q1 2025 May 08, 2025	BUY	$65.37 - $77.96 $6.36 Million - $7.58 Million	97,224 Added 14.13%	785,406 $57.7 Million
Q4 2024 Feb 13, 2025	BUY	$63.2 - $79.58 $6.81 Million - $8.57 Million	107,722 Added 18.56%	688,182 $45.1 Million
Q3 2024 Nov 13, 2024	BUY	$76.67 - $87.62 $3.9 Million - $4.46 Million	50,882 Added 9.61%	580,460 $45.2 Million

Q2 2024 Aug 13, 2024	SELL	$66.81 - $80.83 $5.29 Million - $6.4 Million	-79,195 Reduced 13.01%	529,578 $41.3 Million
Q1 2024 May 08, 2024	BUY	$61.03 - $69.57 $7.41 Million - $8.45 Million	121,428 Added 24.92%	608,773 $41.2 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $5.55 Million - $6.22 Million	-89,724 Reduced 15.55%	487,345 $32.8 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $5.11 Million - $5.65 Million	78,752 Added 15.8%	577,069 $39.1 Million
Q2 2023 Aug 10, 2023	SELL	$69.91 - $75.81 $3.19 Million - $3.46 Million	-45,681 Reduced 8.4%	498,317 $35.7 Million
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $2.06 Million - $2.33 Million	32,550 Added 6.36%	543,998 $37.8 Million
Q4 2022 Feb 02, 2023	SELL	$54.21 - $70.44 $3.19 Million - $4.14 Million	-58,798 Reduced 10.31%	511,448 $34.7 Million
Q3 2022 Nov 04, 2022	SELL	$53.02 - $135.75 $5.05 Million - $12.9 Million	-95,159 Reduced 14.3%	570,246 $31.3 Million
Q2 2022 Aug 01, 2022	SELL	$59.26 - $71.14 $18.1 Million - $21.8 Million	-305,936 Reduced 31.5%	665,405 $44 Million
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $49.4 Million - $59.5 Million	885,947 Added 1037.48%	971,341 $64.4 Million
Q4 2021 Feb 08, 2022	BUY	$54.02 - $63.83 $1.01 Million - $1.19 Million	18,672 Added 27.98%	85,394 $4.97 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $146,122 - $159,877	2,630 Added 4.1%	66,722 $4.01 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $24,355 - $30,270	503 Added 0.79%	64,092 $3.84 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $561,015 - $647,618	-11,896 Reduced 15.76%	63,589 $3.16 Million
Q4 2020 Feb 09, 2021	BUY	$48.52 - $58.02 $3.66 Million - $4.38 Million	75,485 New	75,485 $3.77 Million

Others Institutions Holding AZN

# of Institutions

1,502

Shares Held

500M

Call Options Held

5.64M

Put Options Held

3.2M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Astrazeneca PLC Transaction History